Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 3 (2006), Issue 11 (November)

1. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.
   Proc Natl Acad Sci U S A, 103(45): 16882-7. [Abstract] [Full-text]
2. Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis.
   Bioorg Med Chem Lett, 16(23): 6067-72. [Abstract] [Full-text]
3. Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept.
   Ann Rheum Dis, 65(12): 1649-52. [Abstract] [Full-text]
4. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
   Ann Rheum Dis, 65(12): 1645-8. [Abstract] [Full-text]
5. Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
   Ann Rheum Dis, 65(12): 1572-7. [Abstract] [Full-text]
6. Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan.
   Ann Rheum Dis, 65(12): 1661-3. [Abstract] [Full-text]
7. Patterns of cardiovascular risk in rheumatoid arthritis.
   Ann Rheum Dis, 65(12): 1608-12. [Abstract] [Full-text]
8. Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment.
   Ann Rheum Dis, 65(12): 1558-64. [Abstract] [Full-text]
9. Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US.
   Ann Rheum Dis, 65(12): 1653-7. [Abstract] [Full-text]
10. Benefits of a programme taking advantage of patient-instructors to teach and assess musculoskeletal skills in medical students.
    Ann Rheum Dis, 65(12): 1626-30. [Abstract] [Full-text]
11. A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs.
    Ann Rheum Dis, 65(12): 1578-84. [Abstract] [Full-text]
12. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.
    Ann Rheum Dis, 65(12): 1596-601. [Abstract] [Full-text]
13. Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.
    Ann Rheum Dis, 65(12): 1602-7. [Abstract] [Full-text]
14. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
    Ann Rheum Dis, 65(12): 1620-5. [Abstract] [Full-text]
15. Midkine as a molecular target: comparison of effects of chondroitin sulfate E and siRNA.
    Biochem Biophys Res Commun, 351(4): 915-9. [Abstract] [Full-text]
16. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis.
    AJR Am J Roentgenol, 187(6): 1420-6. [Abstract] [Full-text]
17. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Lancet, 368(9549): 1771-81. [Abstract] [Full-text]
18. Coping with rheumatoid arthritis pain in daily life: within-person analyses reveal hidden vulnerability for the formerly depressed.
    Pain, 126(1): 198-209. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.